JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266080

Human TMED9 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TMED9 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1.

View Alternative Names

GMP25, GP25L2, Glycoprotein 25L2, HSGP25L2G, TMED9_HUMAN, Transmembrane emp24 domain-containing protein 9, Transmembrane emp24 protein transport domain containing 9, gp25L2 protein, p24 family protein alpha 2, p24alpha2, p25

1 Images
Sanger Sequencing - Human TMED9 knockout HEK-293T cell line (AB266080)
  • Sanger seq

Unknown

Sanger Sequencing - Human TMED9 knockout HEK-293T cell line (AB266080)

Homozygous : Insertion of the selection cassette in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266080-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266080 Human TMED9 knockout HEK-293T cell line", "number":"AB266080-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266080-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266080 Human TMED9 knockout HEK-293T cell line", "number":"AB266080-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TMED9
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TMED9 also known as Transmembrane Emp24 Domain-Containing Protein 9 carries out important mechanical roles in cellular processes. TMED9 has a mass of about 25 kDa. It functions as a part of the p24 family of proteins known to help in the transportation of proteins between the endoplasmic reticulum and the Golgi apparatus. TMED9 contains domains that are typical for vesicular transport proteins. This protein expresses largely in various tissues including the liver and kidney where protein transport demands are high.
Biological function summary

The TMED9 protein engages in the regulation of protein transport and maturation within cells. It associates with other p24 proteins to form a complex that modulates trafficking of cargo molecules to their correct destinations. This complex plays a role in ensuring accurate membrane formation and lipid metabolism affecting cellular homeostasis. The interaction of TMED9 with other proteins especially within the p24 family is essential for its functional roles in the secretory pathway.

Pathways

TMED9 engages in the endoplasmic reticulum to Golgi transport pathway. This pathway is responsible for the precise delivery of proteins to the Golgi where they undergo further modification. Its interactions with other p24 family members like TMED2 support its role in vesicular transport. Additionally TMED9 might play roles in lipid metabolism intersecting with pathways where proteins such as apolipoproteins participate influencing cellular lipid balance and energy storage.

TMED9 involvement has been observed in conditions like liver diseases and certain types of cancer. TMED9 dysregulation impacts protein transport pathways contributing to cellular dysfunctions seen in liver cirrhosis. Also in certain cancers TMED9 interacts with proteins like TMED10 potentially affecting cell proliferation and migration. Understanding its role could help in developing therapeutic strategies targeting these pathways in disease contexts.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com